MoneyWorks4Me

Dr. Reddys Laboratories informs about disclosure on related party transactions

28 Nov 2019 Evaluate

Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Reddys Laboratories has informed that it has enclosed the applicable disclosure on related party transactions for the half year ended September 30, 2019, in the requisite format.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..